444 related articles for article (PubMed ID: 15794068)
1. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.
Gosepath J; Brieger J; Lehr HA; Mann WJ
Am J Rhinol; 2005; 19(1):7-13. PubMed ID: 15794068
[TBL] [Abstract][Full Text] [Related]
2. [Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps].
Guo J; Wang X; Tao G; Zhang H; Zhu X; Zhang W; Fan E; Han D
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):83-6. PubMed ID: 12761968
[TBL] [Abstract][Full Text] [Related]
3. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis.
Gosepath J; Brieger J; Mann WJ
Am J Rhinol; 2005; 19(2):111-6. PubMed ID: 15921208
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of vascular permeability factor in nasal polyps].
Yang J; Kong H; Dong Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):297-8. PubMed ID: 11717873
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and children featuring nasal polyps.
Hu KH; Lee FP; Cheng YJ; Huang HM
Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):23-8. PubMed ID: 16987554
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa.
Wittekindt C; Hess A; Bloch W; Sultanie S; Michel O
Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):294-8. PubMed ID: 12115075
[TBL] [Abstract][Full Text] [Related]
7. Expression and distribution of aquaporin-1 in nasal polyps: does it have any significance in edema formation?
Altuntas A; Yilmaz MD; Aktepe F; Kahveci OK; Derekoy S; Dilek H; Serteser M
Am J Rhinol; 2006; 20(1):128-31. PubMed ID: 16539309
[TBL] [Abstract][Full Text] [Related]
8. Vascular permeability factor/vascular endothelial growth factor in nasal polyps.
Vento SI; Wolff CH; Salven PJ; Hytönen ML; Ertama LO; Malmberg CH
Acta Otolaryngol Suppl; 2000; 543():170-4. PubMed ID: 10909012
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patients.
Bateman ND; Shahi A; Feeley KM; Woolford TJ
Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):677-81. PubMed ID: 15533158
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
11. Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions.
Leonardi R; Caltabiano M; Pagano M; Pezzuto V; Loreto C; Palestro G
J Endod; 2003 Mar; 29(3):180-3. PubMed ID: 12669876
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of vascular permeability factor (VPF) in inflammatory cells of nasal polyps].
Yang J; Dong Z; Gao J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 17(2):74-5. PubMed ID: 12833685
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor produced in nasal glands of perennial allergic rhinitis.
Matsune S; Ohori J; Sun D; Yoshifuku K; Fukuiwa T; Kurono Y
Am J Rhinol; 2008; 22(4):365-70. PubMed ID: 18702899
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
Yuksel H; Kose C; Yilmaz O; Ozbilgin K; Degirmenci PB; Pinar E; Kirmaz C
Clin Exp Allergy; 2007 Aug; 37(8):1183-8. PubMed ID: 17651148
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin and enhanced polypogenesis in nasal polyps.
Qiu ZF; Han DM; Zhang L; Zhang W; Fan EZ; Cui SJ; Huang Q; Wang XD
Am J Rhinol; 2008; 22(2):106-10. PubMed ID: 18336724
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression in nasal polyps of aspirin-intolerant patients.
Fruth K; Zhu C; Schramek E; Angermair J; Kassem W; Haxel BR; Schneider A; Mann WJ; Brieger J
Arch Otolaryngol Head Neck Surg; 2012 Mar; 138(3):286-93. PubMed ID: 22431874
[TBL] [Abstract][Full Text] [Related]
17. Effect of vascular endothelial growth factor on nasal vascular permeability.
Matsune S; Ohori J; Yoshifuku K; Kurono Y
Laryngoscope; 2010 Apr; 120(4):844-8. PubMed ID: 20213656
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation.
Ito A; Hirota S; Mizuno H; Kawasaki Y; Takemura T; Nishiura T; Kanakura Y; Katayama Y; Nomura S; Kitamura Y
Pathol Int; 1995 Oct; 45(10):715-20. PubMed ID: 8563931
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of cyclooxigenases (Cox-1 and Cox-2) in nasal respiratory mucosa. Does Cox-2 play a key role in the immunology of nasal polyps?
Gosepath J; Brieger J; Gletsou E; Mann WJ
J Investig Allergol Clin Immunol; 2004; 14(2):114-8. PubMed ID: 15301300
[TBL] [Abstract][Full Text] [Related]
20. Local tissue hypoxia and formation of nasal polyps.
Jiang S; Dong Z; Zhu D; Yang Z
Chin Med J (Engl); 2003 Feb; 116(2):243-7. PubMed ID: 12775240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
